Global Patient Derived Xenograft & PDX Models Market Growth (Status and Outlook) 2024-2030

December 2024 | 103 pages | ID: GF7ECAB4388FEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Patient Derived Xenograft & PDX Models market size was valued at US$ 324.4 million in 2023. With growing demand in downstream market, the Patient Derived Xenograft & PDX Models is forecast to a readjusted size of US$ 586.1 million by 2030 with a CAGR of 8.8% during review period.

The research report highlights the growth potential of the global Patient Derived Xenograft & PDX Models market. Patient Derived Xenograft & PDX Models are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Patient Derived Xenograft & PDX Models. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Patient Derived Xenograft & PDX Models market.

Patient derived xenografts (PDX) are models of cancer where the tissue or cells from a patient's tumor are implanted into an immunodeficient or humanized mouse. PDX models are used to create an environment that allows for the natural growth of cancer, its monitoring, and corresponding treatment evaluations for the original patient.

Global top 5 manufacturers of patient-derived xenograft (PDX) models occupied for a share nearly 45 percent, key players are Crown Bioscience, Champions Oncology, Wuxi Apptec, EPO Berlin-Buch, and Oncodesign, etc. Geographically speaking, Asia Pacific holds the most of global market share, about 35%. North America holds about 30% of share, while Europe followed by nearly 20%. In terms of type, mouse model accounted for nearly 75%, and rat model accounted for a share of 25%,The application of patient-derived xenograft (PDX) models includes preclinical drug development and biomarker analysis. Preclinical drug development shares over 75%, while biomarker analysis shares about 20%.

Key Features:

The report on Patient Derived Xenograft & PDX Models market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Patient Derived Xenograft & PDX Models market. It may include historical data, market segmentation by Type (e.g., Mice Models, Rat Models), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Patient Derived Xenograft & PDX Models market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Patient Derived Xenograft & PDX Models market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Patient Derived Xenograft & PDX Models industry. This include advancements in Patient Derived Xenograft & PDX Models technology, Patient Derived Xenograft & PDX Models new entrants, Patient Derived Xenograft & PDX Models new investment, and other innovations that are shaping the future of Patient Derived Xenograft & PDX Models.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Patient Derived Xenograft & PDX Models market. It includes factors influencing customer ' purchasing decisions, preferences for Patient Derived Xenograft & PDX Models product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Patient Derived Xenograft & PDX Models market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Patient Derived Xenograft & PDX Models market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Patient Derived Xenograft & PDX Models market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Patient Derived Xenograft & PDX Models industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Patient Derived Xenograft & PDX Models market.

Market Segmentation:

Patient Derived Xenograft & PDX Models market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type

• Mice Models
• Rat Models

Segmentation by application

• Pre-clinical Drug Development and Basic Cancer Research
• Biomarker Analysis

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Crown Bioscience
• The Jackson Laboratory
• Champions Oncology
• Charles River Laboratories
• WuXi Apptec
• Oncodesign
• Horizon Discovery
• Pharmatest Services
• Hera Biolabs
• EPO Berlin-Buch
• Xentech
• Urolead

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Patient Derived Xenograft & PDX Models Market Size 2019-2030
  2.1.2 Patient Derived Xenograft & PDX Models Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Patient Derived Xenograft & PDX Models Segment by Type
  2.2.1 Mice Models
  2.2.2 Rat Models
2.3 Patient Derived Xenograft & PDX Models Market Size by Type
  2.3.1 Patient Derived Xenograft & PDX Models Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Patient Derived Xenograft & PDX Models Market Size Market Share by Type (2019-2024)
2.4 Patient Derived Xenograft & PDX Models Segment by Application
  2.4.1 Pre-clinical Drug Development and Basic Cancer Research
  2.4.2 Biomarker Analysis
2.5 Patient Derived Xenograft & PDX Models Market Size by Application
  2.5.1 Patient Derived Xenograft & PDX Models Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Patient Derived Xenograft & PDX Models Market Size Market Share by Application (2019-2024)

3 PATIENT DERIVED XENOGRAFT & PDX MODELS MARKET SIZE BY PLAYER

3.1 Patient Derived Xenograft & PDX Models Market Size Market Share by Players
  3.1.1 Global Patient Derived Xenograft & PDX Models Revenue by Players (2019-2024)
  3.1.2 Global Patient Derived Xenograft & PDX Models Revenue Market Share by Players (2019-2024)
3.2 Global Patient Derived Xenograft & PDX Models Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PATIENT DERIVED XENOGRAFT & PDX MODELS BY REGIONS

4.1 Patient Derived Xenograft & PDX Models Market Size by Regions (2019-2024)
4.2 Americas Patient Derived Xenograft & PDX Models Market Size Growth (2019-2024)
4.3 APAC Patient Derived Xenograft & PDX Models Market Size Growth (2019-2024)
4.4 Europe Patient Derived Xenograft & PDX Models Market Size Growth (2019-2024)
4.5 Middle East & Africa Patient Derived Xenograft & PDX Models Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Patient Derived Xenograft & PDX Models Market Size by Country (2019-2024)
5.2 Americas Patient Derived Xenograft & PDX Models Market Size by Type (2019-2024)
5.3 Americas Patient Derived Xenograft & PDX Models Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Patient Derived Xenograft & PDX Models Market Size by Region (2019-2024)
6.2 APAC Patient Derived Xenograft & PDX Models Market Size by Type (2019-2024)
6.3 APAC Patient Derived Xenograft & PDX Models Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Patient Derived Xenograft & PDX Models by Country (2019-2024)
7.2 Europe Patient Derived Xenograft & PDX Models Market Size by Type (2019-2024)
7.3 Europe Patient Derived Xenograft & PDX Models Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Patient Derived Xenograft & PDX Models by Region (2019-2024)
8.2 Middle East & Africa Patient Derived Xenograft & PDX Models Market Size by Type (2019-2024)
8.3 Middle East & Africa Patient Derived Xenograft & PDX Models Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PATIENT DERIVED XENOGRAFT & PDX MODELS MARKET FORECAST

10.1 Global Patient Derived Xenograft & PDX Models Forecast by Regions (2025-2030)
  10.1.1 Global Patient Derived Xenograft & PDX Models Forecast by Regions (2025-2030)
  10.1.2 Americas Patient Derived Xenograft & PDX Models Forecast
  10.1.3 APAC Patient Derived Xenograft & PDX Models Forecast
  10.1.4 Europe Patient Derived Xenograft & PDX Models Forecast
  10.1.5 Middle East & Africa Patient Derived Xenograft & PDX Models Forecast
10.2 Americas Patient Derived Xenograft & PDX Models Forecast by Country (2025-2030)
  10.2.1 United States Patient Derived Xenograft & PDX Models Market Forecast
  10.2.2 Canada Patient Derived Xenograft & PDX Models Market Forecast
  10.2.3 Mexico Patient Derived Xenograft & PDX Models Market Forecast
  10.2.4 Brazil Patient Derived Xenograft & PDX Models Market Forecast
10.3 APAC Patient Derived Xenograft & PDX Models Forecast by Region (2025-2030)
  10.3.1 China Patient Derived Xenograft & PDX Models Market Forecast
  10.3.2 Japan Patient Derived Xenograft & PDX Models Market Forecast
  10.3.3 Korea Patient Derived Xenograft & PDX Models Market Forecast
  10.3.4 Southeast Asia Patient Derived Xenograft & PDX Models Market Forecast
  10.3.5 India Patient Derived Xenograft & PDX Models Market Forecast
  10.3.6 Australia Patient Derived Xenograft & PDX Models Market Forecast
10.4 Europe Patient Derived Xenograft & PDX Models Forecast by Country (2025-2030)
  10.4.1 Germany Patient Derived Xenograft & PDX Models Market Forecast
  10.4.2 France Patient Derived Xenograft & PDX Models Market Forecast
  10.4.3 UK Patient Derived Xenograft & PDX Models Market Forecast
  10.4.4 Italy Patient Derived Xenograft & PDX Models Market Forecast
  10.4.5 Russia Patient Derived Xenograft & PDX Models Market Forecast
10.5 Middle East & Africa Patient Derived Xenograft & PDX Models Forecast by Region (2025-2030)
  10.5.1 Egypt Patient Derived Xenograft & PDX Models Market Forecast
  10.5.2 South Africa Patient Derived Xenograft & PDX Models Market Forecast
  10.5.3 Israel Patient Derived Xenograft & PDX Models Market Forecast
  10.5.4 Turkey Patient Derived Xenograft & PDX Models Market Forecast
  10.5.5 GCC Countries Patient Derived Xenograft & PDX Models Market Forecast
10.6 Global Patient Derived Xenograft & PDX Models Forecast by Type (2025-2030)
10.7 Global Patient Derived Xenograft & PDX Models Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Crown Bioscience
  11.1.1 Crown Bioscience Company Information
  11.1.2 Crown Bioscience Patient Derived Xenograft & PDX Models Product Offered
  11.1.3 Crown Bioscience Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Crown Bioscience Main Business Overview
  11.1.5 Crown Bioscience Latest Developments
11.2 The Jackson Laboratory
  11.2.1 The Jackson Laboratory Company Information
  11.2.2 The Jackson Laboratory Patient Derived Xenograft & PDX Models Product Offered
  11.2.3 The Jackson Laboratory Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 The Jackson Laboratory Main Business Overview
  11.2.5 The Jackson Laboratory Latest Developments
11.3 Champions Oncology
  11.3.1 Champions Oncology Company Information
  11.3.2 Champions Oncology Patient Derived Xenograft & PDX Models Product Offered
  11.3.3 Champions Oncology Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Champions Oncology Main Business Overview
  11.3.5 Champions Oncology Latest Developments
11.4 Charles River Laboratories
  11.4.1 Charles River Laboratories Company Information
  11.4.2 Charles River Laboratories Patient Derived Xenograft & PDX Models Product Offered
  11.4.3 Charles River Laboratories Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Charles River Laboratories Main Business Overview
  11.4.5 Charles River Laboratories Latest Developments
11.5 WuXi Apptec
  11.5.1 WuXi Apptec Company Information
  11.5.2 WuXi Apptec Patient Derived Xenograft & PDX Models Product Offered
  11.5.3 WuXi Apptec Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 WuXi Apptec Main Business Overview
  11.5.5 WuXi Apptec Latest Developments
11.6 Oncodesign
  11.6.1 Oncodesign Company Information
  11.6.2 Oncodesign Patient Derived Xenograft & PDX Models Product Offered
  11.6.3 Oncodesign Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Oncodesign Main Business Overview
  11.6.5 Oncodesign Latest Developments
11.7 Horizon Discovery
  11.7.1 Horizon Discovery Company Information
  11.7.2 Horizon Discovery Patient Derived Xenograft & PDX Models Product Offered
  11.7.3 Horizon Discovery Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Horizon Discovery Main Business Overview
  11.7.5 Horizon Discovery Latest Developments
11.8 Pharmatest Services
  11.8.1 Pharmatest Services Company Information
  11.8.2 Pharmatest Services Patient Derived Xenograft & PDX Models Product Offered
  11.8.3 Pharmatest Services Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Pharmatest Services Main Business Overview
  11.8.5 Pharmatest Services Latest Developments
11.9 Hera Biolabs
  11.9.1 Hera Biolabs Company Information
  11.9.2 Hera Biolabs Patient Derived Xenograft & PDX Models Product Offered
  11.9.3 Hera Biolabs Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Hera Biolabs Main Business Overview
  11.9.5 Hera Biolabs Latest Developments
11.10 EPO Berlin-Buch
  11.10.1 EPO Berlin-Buch Company Information
  11.10.2 EPO Berlin-Buch Patient Derived Xenograft & PDX Models Product Offered
  11.10.3 EPO Berlin-Buch Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 EPO Berlin-Buch Main Business Overview
  11.10.5 EPO Berlin-Buch Latest Developments
11.11 Xentech
  11.11.1 Xentech Company Information
  11.11.2 Xentech Patient Derived Xenograft & PDX Models Product Offered
  11.11.3 Xentech Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Xentech Main Business Overview
  11.11.5 Xentech Latest Developments
11.12 Urolead
  11.12.1 Urolead Company Information
  11.12.2 Urolead Patient Derived Xenograft & PDX Models Product Offered
  11.12.3 Urolead Patient Derived Xenograft & PDX Models Revenue, Gross Margin and Market Share (2019-2024)
  11.12.4 Urolead Main Business Overview
  11.12.5 Urolead Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Patient Derived Xenograft & PDX Models Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Mice Models
Table 3. Major Players of Rat Models
Table 4. Patient Derived Xenograft & PDX Models Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Patient Derived Xenograft & PDX Models Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Patient Derived Xenograft & PDX Models Market Size Market Share by Type (2019-2024)
Table 7. Patient Derived Xenograft & PDX Models Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Patient Derived Xenograft & PDX Models Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Patient Derived Xenograft & PDX Models Market Size Market Share by Application (2019-2024)
Table 10. Global Patient Derived Xenograft & PDX Models Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Patient Derived Xenograft & PDX Models Revenue Market Share by Player (2019-2024)
Table 12. Patient Derived Xenograft & PDX Models Key Players Head office and Products Offered
Table 13. Patient Derived Xenograft & PDX Models Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Patient Derived Xenograft & PDX Models Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Patient Derived Xenograft & PDX Models Market Size Market Share by Regions (2019-2024)
Table 18. Global Patient Derived Xenograft & PDX Models Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Patient Derived Xenograft & PDX Models Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Patient Derived Xenograft & PDX Models Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Patient Derived Xenograft & PDX Models Market Size Market Share by Country (2019-2024)
Table 22. Americas Patient Derived Xenograft & PDX Models Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Patient Derived Xenograft & PDX Models Market Size Market Share by Type (2019-2024)
Table 24. Americas Patient Derived Xenograft & PDX Models Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Patient Derived Xenograft & PDX Models Market Size Market Share by Application (2019-2024)
Table 26. APAC Patient Derived Xenograft & PDX Models Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Patient Derived Xenograft & PDX Models Market Size Market Share by Region (2019-2024)
Table 28. APAC Patient Derived Xenograft & PDX Models Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Patient Derived Xenograft & PDX Models Market Size Market Share by Type (2019-2024)
Table 30. APAC Patient Derived Xenograft & PDX Models Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Patient Derived Xenograft & PDX Models Market Size Market Share by Application (2019-2024)
Table 32. Europe Patient Derived Xenograft & PDX Models Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Patient Derived Xenograft & PDX Models Market Size Market Share by Country (2019-2024)
Table 34. Europe Patient Derived Xenograft & PDX Models Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Patient Derived Xenograft & PDX Models Market Size Market Share by Type (2019-2024)
Table 36. Europe Patient Derived Xenograft & PDX Models Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Patient Derived Xenograft & PDX Models Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Patient Derived Xenograft & PDX Models Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Patient Derived Xenograft & PDX Models Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Patient Derived Xenograft & PDX Models Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Patient Derived Xenograft & PDX Models Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Patient Derived Xenograft & PDX Models Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Patient Derived Xenograft & PDX Models Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Patient Derived Xenograft & PDX Models
Table 45. Key Market Challenges & Risks of Patient Derived Xenograft & PDX Models
Table 46. Key Industry Trends of Patient Derived Xenograft & PDX Models
Table 47. Global Patient Derived Xenograft & PDX Models Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Patient Derived Xenograft & PDX Models Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Patient Derived Xenograft & PDX Models Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Patient Derived Xenograft & PDX Models Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Crown Bioscience Details, Company Type, Patient Derived Xenograft & PDX Models Area Served and Its Competitors
Table 52. Crown Bioscience Patient Derived Xenograft & PDX Models Product Offered
Table 53. Crown Bioscience Patient Derived Xenograft & PDX Models Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Crown Bioscience Main Business
Table 55. Crown Bioscience Latest Developments
Table 56. The Jackson Laboratory Details, Company Type, Patient Derived Xenograft & PDX Models Area Served and Its Competitors
Table 57. The Jackson Laboratory Patient Derived Xenograft & PDX Models Product Offered
Table 58. The Jackson Laboratory Main Business
Table 59. The Jackson Laboratory Patient Derived Xenograft & PDX Models Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. The Jackson Laboratory Latest Developments
Table 61. Champions Oncology Details, Company Type, Patient Derived Xenograft & PDX Models Area Served and Its Competitors
Table 62. Champions Oncology Patient Derived Xenograft & PDX Models Product Offered
Table 63. Champions Oncology Main Business
Table 64. Champions Oncology Patient Derived Xenograft & PDX Models Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Champions Oncology Latest Developments
Table 66. Charles River Laboratories Details, Company Type, Patient Derived Xenograft & PDX Models Area Served and Its Competitors
Table 67. Charles River Laboratories Patient Derived Xenograft & PDX Models Product Offered
Table 68. Charles River Laboratories Main Business
Table 69. Charles River Laboratories Patient Derived Xenograft & PDX Models Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Charles River Laboratories Latest Developments
Table 71. WuXi Apptec Details, Company Type, Patient Derived Xenograft & PDX Models Area Served and Its Competitors
Table 72. WuXi Apptec Patient Derived Xenograft & PDX Models Product Offered
Table 73. WuXi Apptec Main Business
Table 74. WuXi Apptec Patient Derived Xenograft & PDX Models Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. WuXi Apptec Latest Developments
Table 76. Oncodesign Details, Company Type, Patient Derived Xenograft & PDX Models Area Served and Its Competitors
Table 77. Oncodesign Patient Derived Xenograft & PDX Models Product Offered
Table 78. Oncodesign Main Business
Table 79. Oncodesign Patient Derived Xenograft & PDX Models Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Oncodesign Latest Developments
Table 81. Horizon Discovery Details, Company Type, Patient Derived Xenograft & PDX Models Area Served and Its Competitors
Table 82. Horizon Discovery Patient Derived Xenograft & PDX Models Product Offered
Table 83. Horizon Discovery Main Business
Table 84. Horizon Discovery Patient Derived Xenograft & PDX Models Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Horizon Discovery Latest Developments
Table 86. Pharmatest Services Details, Company Type, Patient Derived Xenograft & PDX Models Area Served and Its Competitors
Table 87. Pharmatest Services Patient Derived Xenograft & PDX Models Product Offered
Table 88. Pharmatest Services Main Business
Table 89. Pharmatest Services Patient Derived Xenograft & PDX Models Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Pharmatest Services Latest Developments
Table 91. Hera Biolabs Details, Company Type, Patient Derived Xenograft & PDX Models Area Served and Its Competitors
Table 92. Hera Biolabs Patient Derived Xenograft & PDX Models Product Offered
Table 93. Hera Biolabs Main Business
Table 94. Hera Biolabs Patient Derived Xenograft & PDX Models Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Hera Biolabs Latest Developments
Table 96. EPO Berlin-Buch Details, Company Type, Patient Derived Xenograft & PDX Models Area Served and Its Competitors
Table 97. EPO Berlin-Buch Patient Derived Xenograft & PDX Models Product Offered
Table 98. EPO Berlin-Buch Main Business
Table 99. EPO Berlin-Buch Patient Derived Xenograft & PDX Models Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. EPO Berlin-Buch Latest Developments
Table 101. Xentech Details, Company Type, Patient Derived Xenograft & PDX Models Area Served and Its Competitors
Table 102. Xentech Patient Derived Xenograft & PDX Models Product Offered
Table 103. Xentech Patient Derived Xenograft & PDX Models Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Xentech Main Business
Table 105. Xentech Latest Developments
Table 106. Urolead Details, Company Type, Patient Derived Xenograft & PDX Models Area Served and Its Competitors
Table 107. Urolead Patient Derived Xenograft & PDX Models Product Offered
Table 108. Urolead Main Business
Table 109. Urolead Patient Derived Xenograft & PDX Models Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Urolead Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Patient Derived Xenograft & PDX Models Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Patient Derived Xenograft & PDX Models Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Patient Derived Xenograft & PDX Models Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Patient Derived Xenograft & PDX Models Sales Market Share by Country/Region (2023)
Figure 8. Patient Derived Xenograft & PDX Models Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Patient Derived Xenograft & PDX Models Market Size Market Share by Type in 2023
Figure 10. Patient Derived Xenograft & PDX Models in Pre-clinical Drug Development and Basic Cancer Research
Figure 11. Global Patient Derived Xenograft & PDX Models Market: Pre-clinical Drug Development and Basic Cancer Research (2019-2024) & ($ Millions)
Figure 12. Patient Derived Xenograft & PDX Models in Biomarker Analysis
Figure 13. Global Patient Derived Xenograft & PDX Models Market: Biomarker Analysis (2019-2024) & ($ Millions)
Figure 14. Global Patient Derived Xenograft & PDX Models Market Size Market Share by Application in 2023
Figure 15. Global Patient Derived Xenograft & PDX Models Revenue Market Share by Player in 2023
Figure 16. Global Patient Derived Xenograft & PDX Models Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Patient Derived Xenograft & PDX Models Market Size 2019-2024 ($ Millions)
Figure 18. APAC Patient Derived Xenograft & PDX Models Market Size 2019-2024 ($ Millions)
Figure 19. Europe Patient Derived Xenograft & PDX Models Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Patient Derived Xenograft & PDX Models Market Size 2019-2024 ($ Millions)
Figure 21. Americas Patient Derived Xenograft & PDX Models Value Market Share by Country in 2023
Figure 22. United States Patient Derived Xenograft & PDX Models Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Patient Derived Xenograft & PDX Models Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Patient Derived Xenograft & PDX Models Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Patient Derived Xenograft & PDX Models Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Patient Derived Xenograft & PDX Models Market Size Market Share by Region in 2023
Figure 27. APAC Patient Derived Xenograft & PDX Models Market Size Market Share by Type in 2023
Figure 28. APAC Patient Derived Xenograft & PDX Models Market Size Market Share by Application in 2023
Figure 29. China Patient Derived Xenograft & PDX Models Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Patient Derived Xenograft & PDX Models Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Patient Derived Xenograft & PDX Models Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Patient Derived Xenograft & PDX Models Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Patient Derived Xenograft & PDX Models Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Patient Derived Xenograft & PDX Models Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Patient Derived Xenograft & PDX Models Market Size Market Share by Country in 2023
Figure 36. Europe Patient Derived Xenograft & PDX Models Market Size Market Share by Type (2019-2024)
Figure 37. Europe Patient Derived Xenograft & PDX Models Market Size Market Share by Application (2019-2024)
Figure 38. Germany Patient Derived Xenograft & PDX Models Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Patient Derived Xenograft & PDX Models Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Patient Derived Xenograft & PDX Models Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Patient Derived Xenograft & PDX Models Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Patient Derived Xenograft & PDX Models Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Patient Derived Xenograft & PDX Models Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Patient Derived Xenograft & PDX Models Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Patient Derived Xenograft & PDX Models Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Patient Derived Xenograft & PDX Models Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Patient Derived Xenograft & PDX Models Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Patient Derived Xenograft & PDX Models Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Patient Derived Xenograft & PDX Models Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Patient Derived Xenograft & PDX Models Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 52. APAC Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 53. Europe Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 55. United States Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 56. Canada Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 59. China Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 60. Japan Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 61. Korea Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 63. India Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 64. Australia Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 65. Germany Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 66. France Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 67. UK Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 68. Italy Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 69. Russia Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 70. Spain Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 73. Israel Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Patient Derived Xenograft & PDX Models Market Size 2025-2030 ($ Millions)
Figure 76. Global Patient Derived Xenograft & PDX Models Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Patient Derived Xenograft & PDX Models Market Size Market Share Forecast by Application (2025-2030)